ACSH is joining several public health and interest groups as an amicus, or friend of the court, to appeal the Food and Drug Administration (FDA) decision to treat e-cigarettes as drug delivery systems rather than as tobacco products.
The science and policy of minimising risks associated with substance use, high-risk behaviours, and public health challenges — grounded in evidence rather than stigma.
